These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 24606860)

  • 21. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
    Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
    Seco J; Gu G; Marcelos T; Kooy H; Willers H
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].
    Guillerme F; Clavier JB; Schumacher C; Falcoz PE; Bourrhala K; Santelmo N; Hassler S; Schott R; Quoix E; Massard G; Noël G
    Cancer Radiother; 2013; 17(4):272-81. PubMed ID: 23712043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver.
    Andolino DL; Forquer JA; Henderson MA; Barriger RB; Shapiro RH; Brabham JG; Johnstone PA; Cardenes HR; Fakiris AJ
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):692-7. PubMed ID: 21288656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Size matters: a comparison of T1 and T2 peripheral non-small-cell lung cancers treated with stereotactic body radiation therapy (SBRT).
    Dunlap NE; Larner JM; Read PW; Kozower BD; Lau CL; Sheng K; Jones DR
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):583-9. PubMed ID: 20478576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between the serum KL-6 level and the grade of radiation pneumonitis after stereotactic body radiotherapy for stage I lung cancer or small lung metastasis.
    Iwata H; Shibamoto Y; Baba F; Sugie C; Ogino H; Murata R; Yanagi T; Otsuka S; Kosaki K; Murai T; Miyakawa A
    Radiother Oncol; 2011 Nov; 101(2):267-70. PubMed ID: 21640420
    [No Abstract]   [Full Text] [Related]  

  • 27. Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning.
    Fritz P; Kraus HJ; Blaschke T; Mühlnickel W; Strauch K; Engel-Riedel W; Chemaissani A; Stoelben E
    Lung Cancer; 2008 May; 60(2):193-9. PubMed ID: 18045732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): planning considerations and early toxicity.
    Ong CL; Palma D; Verbakel WF; Slotman BJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):431-6. PubMed ID: 20971523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
    Dunlap NE; Cai J; Biedermann GB; Yang W; Benedict SH; Sheng K; Schefter TE; Kavanagh BD; Larner JM
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):796-801. PubMed ID: 19427740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locoregional and distant failure following image-guided stereotactic body radiation for early-stage primary lung cancer.
    Nath SK; Sandhu AP; Kim D; Bharne A; Nobiensky PD; Lawson JD; Fuster M; Bazhenova L; Song WY; Mundt AJ
    Radiother Oncol; 2011 Apr; 99(1):12-7. PubMed ID: 21429608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome of four-dimensional stereotactic radiotherapy for centrally located lung tumors.
    Nuyttens JJ; van der Voort van Zyp NC; Praag J; Aluwini S; van Klaveren RJ; Verhoef C; Pattynama PM; Hoogeman MS
    Radiother Oncol; 2012 Mar; 102(3):383-7. PubMed ID: 22265734
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Central-airway necrosis after stereotactic body-radiation therapy.
    Corradetti MN; Haas AR; Rengan R
    N Engl J Med; 2012 Jun; 366(24):2327-9. PubMed ID: 22694017
    [No Abstract]   [Full Text] [Related]  

  • 33. Stereotactic radiotherapy for peripheral lung tumors: a comparison of volumetric modulated arc therapy with 3 other delivery techniques.
    Ong CL; Verbakel WF; Cuijpers JP; Slotman BJ; Lagerwaard FJ; Senan S
    Radiother Oncol; 2010 Dec; 97(3):437-42. PubMed ID: 21074878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment planning of stereotactic radiotherapy for solitary lung tumor.
    Takayama K; Nagata Y; Negoro Y; Mizowaki T; Sakamoto T; Sakamoto M; Aoki T; Yano S; Koga S; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1565-71. PubMed ID: 15817363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endobronchial fiducial to guide stereotactic body radiotherapy.
    Shofer SL; Dunphy F; Mahmood K; Wahidi MM; Yoo D
    J Bronchology Interv Pulmonol; 2013 Jul; 20(3):274-5. PubMed ID: 23857206
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey of stereotactic body radiation therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy Group.
    Nagata Y; Hiraoka M; Mizowaki T; Narita Y; Matsuo Y; Norihisa Y; Onishi H; Shirato H
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):343-7. PubMed ID: 19735861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lung stereotactic body radiation therapy (SBRT) delivered over 4 or 11 days: a comparison of acute toxicity and quality of life.
    Jain S; Poon I; Soliman H; Keller B; Kim A; Lochray F; Yeung L; Cheung P
    Radiother Oncol; 2013 Aug; 108(2):320-5. PubMed ID: 23993401
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: the potential risk of extensive radiation pneumonitis.
    Yamaguchi S; Ohguri T; Ide S; Aoki T; Imada H; Yahara K; Narisada H; Korogi Y
    Lung Cancer; 2013 Nov; 82(2):260-5. PubMed ID: 24054547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
    Iyengar P; Westover K; Timmerman RD
    Semin Respir Crit Care Med; 2013 Dec; 34(6):845-54. PubMed ID: 24258574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.